Sex- and sex hormone-related variations in energy-metabolic frontal brain asymmetries: A magnetic resonance spectroscopy study
Permanent lenke
https://hdl.handle.net/10037/15296Dato
2018-01-31Type
Journal articleTidsskriftartikkel
Peer reviewed
Forfatter
Hjelmervik, Helene; Hausmann, Markus; Craven, Alexander R.; Hirnstein, Marco; Hugdahl, Kenneth; Specht, KarstenSammendrag
Creatine is a key regulator of brain energy homeostasis, and well-balanced creatine metabolism is central in
healthy brain functioning. Still, the variability of brain creatine metabolism is largely unattended in magnetic
resonance spectroscopy (MRS) research. In the human brain, marginal sex differences in creatine levels have been
found in the prefrontal cortex. It is however not known to what degree these sex differences are stable or change
with varying gonadal hormone levels. The current study therefore investigated creatine in the prefrontal cortex
across the menstrual cycle. In addition, we explored cerebral asymmetries. Creatine, Choline (Cho), N-acetylaspartate (NAA), Myo inositol (mI), and glutamate þ glutamine (Glx) were assessed three times in 15 women and 14
men using MRS. Women were tested in cycle phases of varying hormone levels (menstrual, follicular, and luteal
phase). Prefrontal creatine was found to change across the menstrual cycle, in a hemisphere-specific manner.
Women in the follicular phase showed increased left prefrontal creatine accompanied with reduced right prefrontal creatine, while this asymmetry was not present in the luteal phase. In men, the creatine levels remained
stable across three testing sessions. In general, both men and women were found to have higher creatine levels in
the left as compared to the right prefrontal cortex. Exploratory analyses of other metabolites showed similar
asymmetries in NAA, Cho, and mI, while Cho also showed a menstrual cycle effect. This is the first time that sex
hormone-related changes in creatine metabolism have been demonstrated in the human brain. These findings may
have important methodological implications for MRS research, as it supports previous concerns against uncritical
usage of creatine as a reference measure for other metabolites, assumed to be invariant across individuals and
conditions.